COVID-19 Ibuprofen Fears Hit Advil Sales In GSK’s Q2

Reports that ibuprofen could worsen COVID-19 in the early months of the pandemic hit sales of GSK's leading Advil brand, contributing to a drop in pro-forma Consumer Healthcare turnover in the second quarter of 2020.